HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
431.92
-13.85 (-3.11%)
Apr 28, 2026, 4:00 PM EDT - Market closed
HCA Healthcare Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 6,794 | 6,784 | 5,760 | 5,242 | 5,643 | 6,956 | Upgrade
|
| Depreciation & Amortization | 3,593 | 3,523 | 3,312 | 3,077 | 2,969 | 2,853 | Upgrade
|
| Other Amortization | 44 | 44 | 35 | 35 | 29 | 27 | Upgrade
|
| Loss (Gain) From Sale of Assets | -35 | -37 | -14 | 5 | -1,301 | -1,620 | Upgrade
|
| Stock-Based Compensation | 389 | 401 | 360 | 262 | 341 | 440 | Upgrade
|
| Other Operating Activities | 1,482 | 1,503 | 1,167 | 1,267 | 1,993 | 806 | Upgrade
|
| Change in Accounts Receivable | -230 | -94 | -799 | -935 | -797 | -962 | Upgrade
|
| Change in Inventory | 286 | -154 | 334 | -126 | -59 | -540 | Upgrade
|
| Change in Accounts Payable | 676 | 666 | 359 | 604 | -296 | 999 | Upgrade
|
| Operating Cash Flow | 12,999 | 12,636 | 10,514 | 9,431 | 8,522 | 8,959 | Upgrade
|
| Operating Cash Flow Growth | 34.07% | 20.18% | 11.48% | 10.67% | -4.88% | -2.96% | Upgrade
|
| Capital Expenditures | -5,072 | -4,944 | -4,875 | -4,744 | -4,395 | -3,577 | Upgrade
|
| Cash Acquisitions | -435 | -397 | -266 | -635 | -224 | -1,105 | Upgrade
|
| Divestitures | 111 | 269 | 328 | 193 | 1,237 | 2,160 | Upgrade
|
| Investment in Securities | 147 | 72 | -115 | -112 | 14 | -117 | Upgrade
|
| Other Investing Activities | 11 | 12 | -5 | -19 | -21 | -4 | Upgrade
|
| Investing Cash Flow | -5,238 | -4,988 | -4,933 | -5,317 | -3,389 | -2,643 | Upgrade
|
| Long-Term Debt Issued | - | 10,676 | 7,495 | 3,224 | 6,117 | 7,124 | Upgrade
|
| Long-Term Debt Repaid | - | -7,389 | -4,290 | -1,929 | -2,830 | -3,869 | Upgrade
|
| Net Debt Issued (Repaid) | 3,106 | 3,287 | 3,205 | 1,295 | 3,287 | 3,255 | Upgrade
|
| Repurchase of Common Stock | -9,132 | -10,067 | -6,042 | -3,811 | -7,000 | -8,215 | Upgrade
|
| Common Dividends Paid | -682 | -679 | -690 | -661 | -653 | -624 | Upgrade
|
| Other Financing Activities | -1,177 | -1,091 | -1,055 | -917 | -1,290 | -1,071 | Upgrade
|
| Financing Cash Flow | -7,885 | -8,550 | -4,582 | -4,094 | -5,656 | -6,655 | Upgrade
|
| Foreign Exchange Rate Adjustments | 4 | 9 | -1 | 7 | -20 | -3 | Upgrade
|
| Net Cash Flow | -120 | -893 | 998 | 27 | -543 | -342 | Upgrade
|
| Free Cash Flow | 7,927 | 7,692 | 5,639 | 4,687 | 4,127 | 5,382 | Upgrade
|
| Free Cash Flow Growth | 60.21% | 36.41% | 20.31% | 13.57% | -23.32% | -15.87% | Upgrade
|
| Free Cash Flow Margin | 10.38% | 10.17% | 7.99% | 7.21% | 6.85% | 9.16% | Upgrade
|
| Free Cash Flow Per Share | 33.91 | 32.12 | 21.54 | 16.96 | 14.01 | 16.37 | Upgrade
|
| Cash Interest Paid | 2,237 | 2,207 | 1,938 | 1,892 | 1,662 | 1,502 | Upgrade
|
| Cash Income Tax Paid | 1,725 | 1,740 | 1,844 | 1,386 | 1,175 | 2,182 | Upgrade
|
| Levered Free Cash Flow | 5,602 | 5,823 | 3,916 | 2,873 | 3,083 | 4,078 | Upgrade
|
| Unlevered Free Cash Flow | 6,986 | 7,184 | 5,169 | 4,049 | 4,142 | 5,030 | Upgrade
|
| Change in Working Capital | 732 | 418 | -106 | -457 | -1,152 | -503 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.